Published in

Rockefeller University Press, Journal of Experimental Medicine, 11(217), 2020

DOI: 10.1084/jem.20200684

Links

Tools

Export citation

Search in Google Scholar

β-Catenin regulates tumor-derived PD-L1

Journal article published in 2020 by Chuanhui Han, Yang-Xin Fu ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

In this issue of JEM, Du et al. (https://doi.org/10.1084/jem.20191115) report that enhancement of the β-catenin signaling by Wnt or EGF treatment increases the expression of PD-L1 in an AKT and β-catenin–dependent manner, and blocking the AKT pathway synergizes with anti–PD-1 in a glioblastoma model.